Tag: FDA Section 505A

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image History of Generic Drugs in the United States: How Cheap Medicines Became the Norm
recent-post-image How and Where to Buy Allopurinol Online Safely (UK 2025 Guide)
recent-post-image Dry Eye Treatments: Cyclosporine, Lifitegrast, and Plugs Explained
recent-post-image Atrial Fibrillation and Travel: Safe Trip Tips (2025 Guide)
recent-post-image How Air Pollution Fuels Lung Inflammation: Causes, Risks, and Solutions

Menu

© 2026. All rights reserved.